Stay updated on REGN4659+Cemiplimab in Advanced NSCLC Clinical Trial
Sign up to get notified when there's something new on the REGN4659+Cemiplimab in Advanced NSCLC Clinical Trial page.

Latest updates to the REGN4659+Cemiplimab in Advanced NSCLC Clinical Trial page
- Check6 days agoChange DetectedRevision: v3.3.4 appears in the page history, replacing v3.3.3. This is a minor maintenance update to the page's history.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedAdded Revision: v3.3.3 to the history and removed HHS Vulnerability Disclosure and Revision: v3.3.2 from the footer.SummaryDifference0.2%

- Check49 days agoChange DetectedA new revision (v3.3.2) has been added to the record history, and revision v3.3.1 has been removed.SummaryDifference0.1%

- Check56 days agoChange DetectedThe record history shows an administrative update adding Revision: v3.3.1 and removing Revision: v3.2.0; no substantive changes to study data or status are involved.SummaryDifference0.1%

- Check63 days agoChange DetectedNotice about potential data inaccuracies due to a lapse in government funding has been removed. The page no longer displays information about the NIH Clinical Center's status or related government operation updates.SummaryDifference0.8%

- Check78 days agoChange DetectedThe record history shows several version updates with changes to the Study Status and Recruitment Status over time, indicating shifts in the trial's activity and enrollment details.SummaryDifference0.1%

Stay in the know with updates to REGN4659+Cemiplimab in Advanced NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the REGN4659+Cemiplimab in Advanced NSCLC Clinical Trial page.